Autism Spectrum Social Stories In Schools Trial 2 (ASSSIST2) : study protocol for a randomised controlled trial analysing clinical and cost-effectiveness of Social Stories™ in primary schools by Wright, B et al.
This is a repository copy of Autism Spectrum Social Stories In Schools Trial 2 (ASSSIST2)
: study protocol for a randomised controlled trial analysing clinical and cost-effectiveness 
of Social Stories™ in primary schools.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/161995/
Version: Published Version
Article:
Wright, B orcid.org/0000-0002-8692-6001, Teige, C, Watson, J 
orcid.org/0000-0003-0694-3854 et al. (13 more authors) (2020) Autism Spectrum Social 
Stories In Schools Trial 2 (ASSSIST2) : study protocol for a randomised controlled trial 
analysing clinical and cost-effectiveness of Social Stories™ in primary schools. BMC 
Psychology. 60. ISSN 2050-7283 
https://doi.org/10.1186/s40359-020-00427-z
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
STUDY PROTOCOL Open Access
Autism Spectrum Social Stories In Schools
Trial 2 (ASSSIST2): study protocol for a
randomised controlled trial analysing
clinical and cost-effectiveness of Social
Stories™ in primary schools
B. Wright1,2,3*, C. Teige1, J. Watson4, R. Hodkinson1, D. Marshall5, D. Varley6, V. Allgar6, L. Mandefield4, S. Parrott6,
E. Kingsley1, R. Hargate1, N. Mitchell4, S. Ali6,7, D. McMillan6, H. Wang6 and C. Hewitt4
Abstract
Background: Interventions designed to support children with a diagnosis of Autism Spectrum Conditions (ASC)
can be time consuming, needing involvement of outside experts. Social Stories™ are a highly personalised
intervention aiming to give children with ASC social information or describing an otherwise difficult situation or
skill. This can be delivered daily by staff in education settings. Studies examining Social Story™ use have yielded
mostly positive results but have largely been single case studies with a lack of randomised controlled trials (RCTs).
Despite this numerous schools are utilising Social Stories™, and a fully powered RCT is timely.
Methods: A multi-site pragmatic cluster RCT comparing care as usual with Social Stories™ and care as usual. This
study will recruit 278 participants (aged 4–11) with a clinical diagnosis of ASC, currently attending primary school in
the North of England. Approximately 278 school based staff will be recruited to provide school based information
about participating children with approximately 140 recruited to deliver the intervention. The study will be cluster
randomised by school. Potential participants will be screened for eligibility prior to giving informed consent. Follow
up data will be collected at 6 weeks and 6 months post randomisation and will assess changes in participants’
social responsiveness, goal based outcomes, social and emotional health. The primary outcome measure is the
Social Responsiveness Scale Second Edition (SRS-2) completed by school based staff at 6 months. Approvals have
been obtained from the University of York’s Research Governance Committee, Research Ethics Committee and the
Health Research Authority. Study results will be submitted for publication in peer-reviewed journals and
disseminated to participating families, educational staff, local authority representatives, community groups and
Patient and Participant Involvement representatives. Suggestions will be made to NICE about treatment evidence
dependent on findings.
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Discussion: This study addresses a much used but currently under researched intervention and results will inform
school based support for primary school children with a diagnosis of ASC.
Trial registration: The trial is registered on the ISRCTN registry (registration number: ISRCTN11634810). The trial
was retrospectively registered on 23rd April 2019.
Keywords: Social stories, Autism Spectrum conditions, School based interventions, Child mental health, Education
Background
Autism Spectrum Disorders, often termed Autism
Spectrum Conditions (ASC) [1] affects at least 1% of chil-
dren in the UK [2]. ASC is a lifelong neurodevelopmental
condition that can impact upon a range of child and adult
outcomes [3, 4]. Children with ASC have a range of difficul-
ties with social communication, sensory processing differ-
ences, and may have repetitive behaviours [5] and/or
preoccupations [6]. They experience a higher prevalence of
mental health problems than typically developing children
including anxiety and low mood [7]. Many children with
ASC struggle to manage social anxiety and feelings of frus-
tration, which can lead to challenging behaviour [8–10]. Re-
search shows that many people with ASC have additional
care needs, both in the NHS and social care across child-
hood and adulthood [11, 12].
Social norms and classroom expectations can be diffi-
cult for children with ASC to learn and understand [13]
and teachers facing many demands on their time and
with limited training opportunities, may struggle to sup-
port their education [14].
Carol Gray’s Social Stories™ are short, highly individua-
lised stories that provide children with social information.
They help children with ASC more easily understand a
situation personal to them such as learning life skills, new
experiences, understanding emotions (or people), transi-
tions or change. The child is included in the narrative
often with a range of helpful visual information. They are
child friendly and do not require extensive involvement
from outside experts [15]. Social Stories™ are defined by
ten criteria that guide story development [16]. These help
to ensure stories remain patient and supportive in tone
using relevant, tailored content that is descriptive, mean-
ingful, and safe for the child. The capacity for tailoring
these stories is particularly important for helping children
with ASC across a range of ages, strengths, difficulties and
needs [17, 18]. Previous research examining Social Story™
use in specialist and mainstream education [19, 20] and
within the home [18] shows largely positive results [21],
and suggests that Social Stories™ may promote calmer
classrooms with improved learning and better integration
in Special Educational Needs (SEN) [19] and mainstream
settings [20]. Children with ASC have shown improve-
ments in social interactions [22–24], decision making [23],
self awareness in communication [24] and mealtime skills
[25]. Success has also been reported in reducing tantrums
[26, 27] and managing frustration [28]. This research also
suggests that it is possible to train tier one professionals,
for example teachers, to develop and use Social Stories™
tailored to a child [29].
Despite this research, two systematic reviews of their
effectiveness [30, 31] indicate large gaps in the literature.
The reviews mainly identify single case designs and a
lack of randomised controlled trial evidence.
This research is needed now because numerous
schools utilise Social Stories™ despite a limited evidence
base. This is highly relevant when many providers face
limited resources for children with neurodevelopmental
problems and mental health problems. Given that spe-
cialist practitioner interventions are in short supply, in-
terventions such as Social Stories™ deserve robust
evaluation as they can be delivered within schools on a
day to day basis. We will be exploring these aspects
within our study. This study follows an RCT that
assessed the feasibility and acceptability of running a
trial examining Social Story™ use in both primary and
secondary mainstream schools [32]. This demonstrated a
high degree of acceptability with young people, family
and schools. This main trial now seeks to assess the clin-
ical and cost-effectiveness of Social Stories™, addressing
the lack of fully powered RCTs in this area.
Study aim
To assess the clinical and cost-effectiveness of Social
Stories™ alongside care as usual in primary schools when
compared with care as usual alone.
Study objectives
Primary
The primary objective of the study is to establish
whether Social Stories™ can improve social responsive-
ness in children with ASC in primary schools across
Yorkshire and the Humber, when compared to children
who have received care as usual only.
Secondary
The secondary objectives of this trial are:
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1. To investigate whether Social Stories™ can reduce
challenging behaviour in children with ASC in
primary schools.
2. To investigate whether Social Stories™ can improve
social and emotional health in children with ASC in
primary schools.
3. To assess the cost-effectiveness of Social Stories™.
4. To examine the effects of Social Stories™ delivered
in the classroom on general measures of health
related quality of life.
5. To examine whether Social Stories™ improve
classroom attendance.
6. To assess sustainability of Social Stories™ in an
education setting across a 6 month period.
7. To examine any changes in parental stress.
8. To examine any associations between treatment
preference and outcomes.
9. To examine how elements of session delivery (e.g.
session frequency, length and any associated
problems/adverse events) are associated with
outcomes.
Trial design
This trial is a multi-site pragmatic cluster RCT compar-
ing Social Stories™ and care as usual with a control
group receiving care as usual alone. Care as usual is de-
fined as the existing support routinely provided for a
child with ASC from educational and health services
such as specialist autism teacher teams, mental health
teams or other associated professionals. The trial in-
cludes a 10 month internal pilot, a process evaluation
(including qualitative interviews and an examination of
treatment fidelity) and an economic evaluation.
Methods
Study setting
Participants will be recruited using a variety of methods
including identification through schools, or identification
through participating NHS trusts using their clinic lists/
databases. Intervention delivery will take place in the
participant’s school.
Eligibility criteria
Both the school and the child’s parents/guardians must
agree to take part before either may be included. Eligibil-
ity to take part will be ascertained using the following
criteria.
Inclusion criteria:
 The child is aged 4–11 years.
 The child attends a participating primary school
within Yorkshire and the Humber.
 The child has a clinical diagnosis of ASC and daily
challenging behaviour.
 Parents/guardians of the child are able to self-
complete the English language outcome measures
(with assistance if necessary).
Exclusion criteria:
 The school has used Social Stories™ for any pupil in
the current or preceding school term.
 The child or interventionist teacher has taken part
in the previous Social Stories™ feasibility study
(ASSSIST). Schools that have taken part will not be
excluded.
Intervention
Children in the intervention arm of the trial will receive
the Social Stories™ intervention in addition to their care
as usual.
The Social Stories™ intervention will be delivered by a
trained educational professional (the interventionist) who
is employed within each school allocated to the interven-
tion arm. The interventionist may vary between the
schools (e.g. a teacher, teaching assistant (TA), or Special
Educational Needs Coordinator (SENCO)). Social Stories™
used within the trial will be based on a goal developed
mainly by an education professional who knows the par-
ticipating child well but is not the interventionist (the as-
sociated teacher). This goal will be developed with
support from the study team; and where possible the par-
ent/guardian, interventionist and the child. A Social Story™
is used to provide a child with social information and
works well if a child is uncertain or finds a situation dis-
tressing, frustrating or incomprehensible.
Interventionists will be trained by the research team or
through trained local authority autism specialist staff.
Training will include information on the design and im-
plementation of Social Stories™, with materials based on
those developed in the preceding feasibility study with
the support of Carol Gray [32] and a Social Stories™
manual produced by the study’s Chief Investigator (CI)
and a Clinical Psychologist with expertise in autism [33].
During the training session, interventionists will con-
struct a Social Story™. Parents/guardians will also be in-
vited to attend these sessions. Following training all
Social Stories™ will be assessed against a fidelity check-
list, to ensure they conform to the ten established cri-
teria [16, 33]. They will then be delivered to children in
the intervention arm by the interventionist at least six
times over a 4 week period.
Goal based outcome measures will be used and 20 %
of children allocated to the intervention arm will be
observed by a blinded research assistant to ascertain
their progress towards the goal. Consent to these
observations will be optional and participants will be
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randomly selected by the Trials Unit using a computer
generated list from those who have opted in.
Control
Participants allocated to the control arm of the trial will
receive care as usual. Schools in the control arm are
asked to refrain from delivering any Social Stories™ for
the duration of their trial involvement.
If a participant decides to withdraw from the interven-
tion and/or the study, a member of the research team
will record details including reasons provided, whether
withdrawal is from the whole study or an individual
element, and whether they wish to continue providing
data for analysis.
Outcomes (primary and secondary)
Baseline and follow-up measures will be collected during
visits to schools, participants’ homes or at locations con-
venient to participants or via post where face to face
data collection is not possible. The primary outcome is
the Social Responsiveness Scale, Second Edition (SRS-2)
[34] completed at 6 months post-randomisation by the
associated teacher. The SRS-2 measures social inter-
action skills and ASC symptomatology.
All secondary outcomes are listed below (grouped by
respondent) and will be collected at baseline, 6 weeks
and 6 months post-randomisation unless specified. The
trial flow chart is seen in Fig. 1.
Parent questionnaires:
1. Social Responsiveness Scale, Second Edition (SRS-2)
[34].
2. Demographic information pertaining to the child
and the parent – baseline only.
3. Parenting Stress Index short form [35].
4. The EQ-5D-Y (proxy) [36].
5. Revised Children Anxiety and Depression Scale
(RCADS) short form [37].
6. Bespoke resource use questionnaire, capturing
healthcare and non-health resource use of partici-
pants and parents/carers– baseline and 6 months
only.
7. Bespoke treatment preference questionnaire –
baseline only.
Associated teacher/TA questionnaires:
1. Social Responsiveness Scale, Second Edition (SRS-2)
[34].
2. A goal-based outcome measure (adapted from the
Child Outcomes Research Consortium) [38].
3. Bespoke resource use questionnaire – baseline and
6 months only.
4. Bespoke treatment preference questionnaire –
baseline only.
5. Bespoke resource use questionnaire determining
current school care/education plan interventions –
baseline and 6 months only.
Interventionist Teacher/ TA Questionnaires:
1. Bespoke Social Story™ session log. – used after each
Social Story™ session.
2. A bespoke sustainability questionnaire – 6 weeks
and 6 months only.
Process Evaluation - Researcher Questionnaires:
1. A fidelity checklist (intervention arm only) assessing
each Social Story™ - after the story has been created
and at 6 weeks post-randomisation.
2. A goal-based measure – used when observing ran-
domised children at 6 weeks and 6 months.
Sample size calculation
The primary outcome is the teacher completed SRS-2 t-
score at 6 months. Within the pilot data, outcomes were
measured at 6 and 16 weeks. The correlation between
baseline and 6 weeks (r = 0.67, 95% CI 0.44 to 0.80) was
lower than that at 16 weeks (r = 0.83, 95% CI 0.68 to
0.91) for the pilot data. To be conservative we have
chosen the lower 95% confidence limit for the lowest
correlation between baseline and follow-up that we ob-
served within our pilot data (r = 0.44). Assuming a dif-
ference of 3 points, SD = 7, 5% alpha, 90% power,
average cluster size 1.35, ICC = 0.34, correlation = 0.44
and 25% attrition requires a total sample size of 278.
Recruitment
The study aims to recruit 278 children with ASC from
across Yorkshire and the Humber. Recruitment opened
in November 2018. In addition, the study will recruit
278 parents/guardians, 278 associated teachers and ap-
proximately 140 interventionists who will each complete
study questionnaires, and in the case of interventionists,
deliver Social Stories™ sessions.
ASSSIST2 will use five methods of participant recruit-
ment outlined in more detail below:
Recruitment from schools
Primary schools across Yorkshire and the Humber will
be contacted with information about the trial. Where
schools agree to participate they will be asked to send
information sheets and Expression of Interest (EOI)
forms to parents/guardians of eligible children. Parents/
guardians who return an EOI form or have consented
for school staff to pass on their details will be contacted
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by a member of the research team to discuss the trial,
answer any questions and to arrange collection of in-
formed consent from parents/guardians and where pos-
sible assent from the child. We will also gain consent
from education professionals taking part in the trial.
Recruitment from NHS sites
Participating NHS Trusts who carry out autism
spectrum assessments will be asked to identify poten-
tially eligible families through screening of their clinic/
database lists. A member of the clinic team (or delegated
staff member) will send study information and EOI
forms to the child’s parent/guardian. Recruitment will
then follow the procedure set out for schools.
Recruitment from local community groups
Local community groups within the catchment area,
e.g. the Autism Spectrum Conditions - Enhancing
Nurture and Development (ASCEND) parent group
[39], will be contacted with information about the
trial and researchers will distribute study information
to interested parents/guardians. On receipt of an
EOI, recruitment will follow the procedure outlined
for schools.
Fig. 1 Study Flow Chart
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Liaising with local authority professionals
Relevant local authority professionals, e.g. educational
specialists in ASC, will be contacted and asked to dis-
seminate study information and EOI forms to the par-
ents/guardians of potentially eligible children. On receipt
of an EOI recruitment will follow the procedure outlined
for schools.
Recruitment from local publicity
Families may hear about the trial from a range of
sources and contact the research team. In this instance
the team will confirm the child’s eligibility and send out
study information. It will be made clear that participa-
tion is dependent on the child’s school taking part and
recruitment will continue in line with the procedure out-
lined for schools.
Randomisation
Randomisation will occur after consent/assent and base-
line data has been obtained from all participating fam-
ilies and educational professionals within a school.
Remote randomisation for the trial will be carried out by
the York Trials Unit (YTU). Schools will be randomised
using cluster randomisation to reduce the risk of con-
tamination within schools with multiple participating
children. Randomisation will be stratified by school type
(SEN school or mainstream school) and by the number
of participating children within a school (≤5 or > 5 par-
ticipating children).
Following randomisation schools will be notified of
study allocation via phone call, email and following let-
ter. Participating parents/guardians will receive a con-
firmatory letter.
Blinding
Research assistants collecting outcome data and the main
trial statistician will be blinded to study allocation until final
data analysis. It is not possible for children, parents/guard-
ians or school staff to be blinded to study allocation due to
the nature of the intervention. The Data Monitoring and
Ethics Committee (DMEC) will have access to un-blinded
data throughout the study. Any instances of un-blinding
will be recorded using a bespoke form. In such instances a
substitute blinded research assistant will collect participant
data wherever possible.
Data collection
Data collection will utilise paper Case Report Forms
(CRFs). To maintain participant confidentiality CRFs will
be anonymised using participant ID numbers. Data collec-
tion will occur at baseline, 6 weeks and 6 months post-
randomisation. Wherever possible baseline CRFs will be
completed in person and where not possible, participants
will be offered the option to return them by post.
Data management
All information collected during the study will be kept
strictly confidential and stored on a secure password
protected server located at the University of York, for
the purposes of assisting in follow-ups during the study.
All paper documents will be stored securely.
CRFs will be initially checked for errors by the re-
search team and any queries raised immediately with
participants. CRFs will then be logged on the YTUs be-
spoke data management system and scanned using Car-
diff Teleform. Original datasheets will be securely stored
at YTU. All data will be collected and retained in ac-
cordance with the Data Protection Act 2018, the General
Data Protection Regulation 2018 and YTU standard op-
erating procedures (SOPs). All data will be archived for
10 years following the end of the study and then securely
destroyed.
Statistical analysis
Statistical analyses will be conducted using a validated
statistical software package and will be reported in line
with the Consolidated Standards of Reporting Trials
(CONSORT) 2010 Statement [40]. The primary analysis
population will be intention to treat (ITT).
Primary and secondary outcomes analysis
The primary analysis will compare teacher reported
SRS-2 t-scores measured at 6 months between the ran-
domised groups using a covariance pattern mixed model.
Important baseline covariates, baseline SRS-2 t-score, the
SEN status of the child’s school (SEN vs. non-SEN), the
number of recruited children in the child’s school (> 5
vs. ≤5), time point, treatment group, and a treatment
group-by-time point interaction will be included as fixed
effects and school will be included as a random effect.
SRS-2 t-scores at 6 weeks post randomisation will be in-
corporated as outcome data. The model will account for
the correlation of scores within pupil over time by
means of an appropriate covariance structure. Interven-
tion effects in the form of an adjusted mean difference
will be presented with an associated 95% CI and p-value
for both time points (6 weeks and 6 months).
Secondary outcomes will be analysed in a similar man-
ner to the primary analysis, adjusting for the appropriate
baseline score being tested. The summary of Adverse
Events (AEs) and Serious Adverse Events (SAEs) experi-
enced by participants will be reported by treatment group.
Subgroup analyses will be performed to explore the
potential effect of teacher’s preferred randomisation
group collected at baseline. The primary analysis model
will be refitted with an interaction term between the
randomisation group and teacher’s preference. A Com-
plier Average Causal Effect analysis for the primary
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outcome will be considered to account for compliance
with the intervention at the student level.
Process evaluation
The process evaluation will include an interventionist
questionnaire, capturing how many times intervention-
ists have used Social Stories™; and whether they have
trained others. Interviews and fidelity assessment will be
carried out. A Social Story™ writing and delivery training
DVD will be developed and an FAQ document identify-
ing elements of good practice in the implementation of
Social Stories™ as well as any common issues or barriers
highlighted by interventionists and/or parents. Both of
these outputs will be freely available on the research
team’s website.
Qualitative analysis
Semi-structured interviews will be undertaken with 10–20
participants to explore challenges and barriers to training
and implementation of Social Stories™, and the willingness
of school staff to run the intervention independently.
These participants will be purposively selected from the
cohort of teachers, trainers, interventionists, Associated
Teachers, local authority representatives involved in the
trial and parents who attended the training. With consent,
all interviews will be recorded on encrypted devices, tran-
scribed verbatim and anonymised. A sample of data
transcripts will be checked against audio recordings for
accuracy. Interview material will be organised according
to analytical headings using a constant comparison ap-
proach [41]. Qualitative data analysis computer software
will be used to structure and explore the interview data.
Electronic sound files and transcripts from qualitative in-
terviews will be assigned a unique participant number,
known only to relevant members of the research team.
Any quotes published will be anonymous.
Fidelity analysis
The fidelity evaluation will examine the extent to which
the components of the intervention (Social Stories™)
were delivered as planned, and the accommodations re-
quired by schools to ensure this. Interventionists’ adher-
ence to core components will be assessed via researcher
completed fidelity checklists of each Social Story™ after
initial writing and at 6 weeks.
Economic analysis
The economic analysis will be conducted from an NHS
and Personal Social (PSS) perspective, taking the form of
a within-trial cost-effectiveness analysis determining the
incremental cost per unit of outcome effectiveness meas-
ure for Social Stories™ compared with care as usual in
children with autism. Health outcomes will be measured
in terms of quality-adjusted life-years (QALYs) using the
EQ-5D-Y (proxy version) as a health descriptor measure
(the preferred instrument in the NICE reference case).
The domains of the EQ-5D-Y proxy will then be valued
using UK population tariff to provide utility scores at
multiple time points. QALYs will be estimated using
time weighted averages of the utility scores measured
over the study time period.
The cost of the Social Stories™ intervention will be cal-
culated using a bottom-up estimation of the time spent
by professionals delivering the intervention, the cost of
training and other resources used. Unit costs of health
service use will be obtained from the UK national data-
base of reference costs. The cost of social services will
be calculated from the Unit Costs of Health and Social
Care, produced by the Personal Social Services Research
Unit, and the cost of other professional support will be
estimated from relevant salary scales and published re-
ports/ literature.
A sensitivity analysis will be conducted including costs
of productivity loss.
Data monitoring
The conduct of the study will be governed by three
committees.
 A Trial Steering Committee (TSC).
 An independent Data Monitoring and Ethics
Committee (DMEC).
 A Trial Management Group (TMG).
These committees will function in accordance with
YTU SOPs. The DMEC and TSC are both independent
from the sponsor. The TSC will consist of an independ-
ent chair, an independent subject specialist, an inde-
pendent clinical academic, an independent statistician
and a Patient and Public Involvement (PPI) representa-
tive. The DMEC will consist of an independent chair, an
independent statistician, and another independent mem-
ber experienced in research with children and families.
The TSC and DMEC will meet approximately every 6
months from the start of the trial. The TMG will com-
prise co-applicants, members of the trial team (including
the data manager), PPI representatives, and the trial
managers. Co-applicants and trial team members will be
invited as required depending on their roles.
Adverse event reporting
Possible harm as a result of the study will be monitored
according to YTU SOPs. Any Adverse Events (AEs) re-
ported by individuals participating in the study will be
recorded using a bespoke Adverse Events Recording
Form and assessed for seriousness. AEs will be recorded
as a Serious Adverse Event (SAE) if it results in death, is
life threatening, prolongs or requires hospitalisation, or
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results in disability or incapacity. Any AEs relating to
study participation and all SAEs will be reported to the
CI. SAEs related to the study will be reported to the
study Sponsor, DMEC and TSC.
The DMEC will review data throughout the trial for
safety. If there is evidence of harm due to the interven-
tion or measures used, the DMEC will advise the TSC
with a possible recommendation to stop the trial.
Protocol amendments
Prior to submission for ethical approval, protocol amend-
ments will be approved by the CI, substantial amendments
will be approved by the CI, Sponsor and TMG. Amend-
ment history will be tracked by adopting version control
and by the use of an amendment log.
Dissemination
Results will be published in mainstream and specialist
science journals. Study findings will be presented at rele-
vant research conferences, symposia and seminars. In
addition, the National Autistic Society and members of
service user groups such as ASCEND will be consulted
in the development of methods for dissemination that
will be effective in reaching families of children with
ASC. We will also produce a short summary of results
that can be distributed to trial participants as well as
relevant interest and patient groups. We will publish
findings on relevant websites such as the National Autis-
tic Society, university and child mental health websites.
We aim to ensure coverage of our findings in the wider
media by issuing a press release.
Towards the end of the trial, our PPI representatives
will organise a meeting with stakeholders including par-
ents and professionals working with young people who
have ASC to discuss the dissemination of the study find-
ings. We will hold a research dissemination event for na-
tional and local clinicians and policy makers. Depending
on findings, we will make suggestions to NICE about
treatment evidence.
Discussion
This study aims to examine the clinical and cost effect-
iveness of Social Stories™ intervention when used in
education settings with primary school children. This
large scale trial builds upon the initial feasibility work
conducted [32], and will enhance a growing body of
promising literature [15, 18–31] by comparing the
outcomes of children receiving care as usual only and
children receiving Social Stories™ in addition to care as
usual in a fully powered RCT. Results from this study
will help to inform school based interventions for
children with a diagnosis of ASC.
Study limitations
Due to the nature of the intervention it is not possible
for participants to be blinded to study allocation, how-
ever the trial research assistants well as the trial statisti-
cian remain blinded to help mitigate any potential
impacts. Further this study focusses solely on the use of
Social Stories™ in education based settings, dependent
on study findings, further randomised research into the
use of Social Stories™ in the home may prove beneficial.
Abbreviations
AEs: Adverse Events; ASC: Autism Spectrum Conditions; ASCEND: Autism
Spectrum Conditions – Enhancing Nurture and Development;
ASSSIST2: Autism Spectrum Social Stories In Schools Trial 2; CACE: Complier
Average Causal Effect; CI: Chief Investigator; CONSORT: Consolidated
Standards of Reporting Trials; CRFs: Case Report Forms; DMEC: Data
Monitoring and Ethics Committee; EOI: Expression of Interest; HRA: Health
Research Authority; ISRCTN: International Standardised Randomised
Controlled Trial Number; ITT: Intention to treat; NICE: The National Institute
for Health and Care Excellence; NIHR: National Institute of Health; PPI: Patient
and Public Involvement; PSS: Personal Social; QALYs: Quality Adjusted Life
Years; RCADS: Revised Children Anxiety and Depression Scale;
RCT(s): Randomised Controlled Trial(s); SAEs: Serious Adverse Events;
SEN: Special Educational Needs; SENCO: Special Educational Needs
Coordinator; SOPs: Standard Operating Procedures; SRS-2: Social
Responsiveness Scale Second Edition; TA: Teaching Assistant; TMG: Trial
Management Group; TSC: Trial Steering Committee; YTU: York Trials Unit
Acknowledgments
We would like to thank the families, teachers and researchers involved in the
feasibility research prior to this who have helped to shape this study. We
would also like to thank Trial managers Jane Blackwell, Kerry Bell and Shirley
Paul for support in developing the protocol from the feasibility study and
the trial management group including Anne McKelvey, Ann McLaren and
Simon Gilbody. Holly Judge from the National Autistic Society has given
invaluable advice. Thanks also to Louise Meehan.
Authors’ contributions
BW is the study CI and chair of the TMG. BW, DM1, JW, DV, VA, RH2, SA, DM2
and CH were responsible for initial conception and design of the study and
the draft of the protocol. CT, RH1, LM, EK and NM were responsible for
substantial alteration to the protocol and design of the study and the
acquisition of data. SP, SA and HW were responsible for the design and
analysis of the health economic component of the trial. LM and CH were
responsible for the design of the statistical analysis sections of the trial. All
authors made substantial contribution to the drafting, critical revision and
final approval of the document.
Funding
This paper is independent research funded by the National Institute for
Health Research (NIHR Health Technology Assessment, 16/111/91 – Autism
Spectrum Social Stories In Schools Trial 2 (ASSSIST2): A randomised
controlled trial and economic evaluation of a Social Stories intervention to
address the social emotional health of children with ASD in primary schools).
The views expressed in this publication are those of the authors and not
necessarily those of the NHS, the National Institute for Health Research or
the Department of Health and Social Care. The funder allows researchers full
independence but makes certain requirements to ensure that there is good
research governance. This includes requiring the research team to have an
independent Trial Steering Group, and independent Data Monitoring Ethics
Committee and to report quarterly on milestone progress. They also require
funded studies to follow the Good Clinical Practice guidelines laid out by the
International Committee for Harmonisation (ICH- GCP).
Availability of data and materials
Anonymised participant data from the ASSSIST2 trial will be made available
via the sponsor. Those wishing to access this data must apply to the sponsor
and show that they have sound scientific reasons for requesting access to
the data as well as having acceptable research methods. Other documents
Wright et al. BMC Psychology            (2020) 8:60 Page 8 of 10
that will be made available include the study’s protocol, statistical analysis
plan, health economics plan as well as the case report forms used
throughout the study. This data will become available following publication.
Ethics approval and consent to participate
Ethical approval for the study was granted by the University of York’s
Department of Health Sciences Research Governance Committee on 3rd
September 2018 (Reference: HSRGC/2018/286/D), Research Ethics Committee
approval was granted on 23rd July by Health and Care Research Wales
(Reference: 19/NE/0237) and Health Research Authority (HRA) approval was
granted on 24th July 2019 (Reference: 19/NE/0237). Any changes to study
documents will be reviewed and approved in line with HRA requirements
and annual reports will be sent to the HRA. Written consent to participate in
the research study will be obtained from all participating parents/guardians,
Associated Teachers and Interventionists, parents/guardians will provide
written consent on behalf of their participating child/children and written
assent will be obtained from participating children wherever possible.
Consent for publication
Not applicable.
Competing interests
A copy of the Social Stories™ manual (co-developed by Barry Wright – study
CI) is provided to all participating schools and is used during the study
training sessions. This was developed during the feasibility study. All royalties
earned by Barry Wright have to date been given to charity as part of a
written agreement not to profit from this work.
Author details
1Child Oriented Mental Health Intervention Centre, Leeds and York
Partnership NHS Foundation Trust, York, UK. 2Hull York Medical School,
University of York, York, UK. 3COMIC, IT Centre, Innovation Way, Heslington,
York YO10 5NP, UK. 4York Trials Unit, Department of Health Sciences,
University of York, York, UK. 5Centre for Reviews and Dissemination,
University of York, York, UK. 6Department of Health Sciences, University of
York, York, UK. 7Department of Epidemiology and Biostatistics, Schulich
School of Medicine, Western University, London, Ontario, Canada.
Received: 8 May 2020 Accepted: 5 June 2020
References
1. Baron-Cohen S. ASD vs. ASC: Is One Small Letter Important? In: Presented at
International Society for Autism Research Conference. Salt Lake City; 2015.
https://insar.confex.com/imfar/2015/webprogram/Paper19861.html.
Accessed 1 Feb 2020.
2. Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, et al.
Prevalence of disorders of the autism spectrum in a population cohort of
children in South Thames: the Special Needs and Autism Project (SNAP).
Lancet. 2006;368(9531):210–5. https://doi.org/10.1016/S0140-6736(06)69041-7.
3. Russell G, Rodgers LR, Ukoumunne OC, Ford T. Prevalence of parent-
reported ASD and ADHD in the UK: findings from the Millennium Cohort
Study. J Autism Dev Disord. 2014;44(1):31–40. https://doi.org/10.1007/
s10803-013-1849-0.
4. Baron-Cohen S, Scott F, Allison C, Willaims J, Bolton P, Matthews FE, et al.
Prevalence of autism spectrum condition: UK school-based population
study. Br J Psychiatry. 2009;194:500–9. https://doi.org/10.1192/bjp.bp.108.
059345.
5. Turner M. Repetitive behaviour in autism: a review of psychological
research. J Child Psychol Psychiatry. 1999;40(6):839–49. https://doi.org/10.
1111/1469-7610.00502.
6. American Psychiatric Association. Diagnostic and statistical manual of
mental disorders. 5th ed. Washington, DC: APA Press; 2013.
7. Kim JA, Szatmari P, Bryson SE, Streiner DL, Wilson FJ. The prevalence of
anxiety and mood problems among children with autism and Asperger
syndrome. Autism. 2000;4(2):117–32. https://doi.org/10.1177/
1362361300004002002.
8. Koegel LK, Koegel RL, Hurley C, Frea WD. Improving social skills and disruptive
behavior in children with autism through self-management. J Appl Behav Anal.
1992;25(2):341–53. https://doi.org/10.1901/jaba.1992.25-341.
9. White SW, Kreiser NL, Pugliese C, Scarpa A. Social anxiety mediates the
effect of autism spectrum disorder characteristics on hostility in young
adults. Autism. 2012;16(5):453–64. https://doi.org/10.1177/
1362361311431951.
10. Donno R, Parker G, Gilmour J, Skuse DH. Social communication deficits in
disruptive primary-school children. Br J Psychiatry. 2010;196(4):282–9.
https://doi.org/10.1192/bjp.bp.108.061341.
11. National Institute for Health and Care Excellence. The management and
support of children and young people on the autism spectrum. London:
NICE; 2013. Available at: https://www.nice.org.uk/guidance/cg170/evidence/
autism-managment-of-autism-in-childrenand-young-people-full-guideline-24
8641453 Accessed 21 Sept 2017.
12. National Audit Office. Annual Report. London: National Audit Office; 2009.
Available at: https://www.nao.org.uk/report/national-audit-office-annual-
report-2009/. Accessed 21 Sept 2017.
13. Travis L, Sigman M, Ruskin E. Links between social understanding and social
behaviour in verbally able children with autism. J Autism Dev Disord. 2001;
31(2):119–30. https://doi.org/10.1023/A:1010705912731.
14. Simpson R, De Boer-Ott S, Smith-Myles B. Inclusion of learners with Autism
Spectrum Disorders in general education settings. Top Lang Disord. 2003;23:
116–34. https://doi.org/10.1097/00011363-200304000-00005.
15. Scattone D, Tingstrom D, Wilczynski S. Increasing appropriate social
interactions of children with Autism Spectrum Disorders using Social
Stories™. Focus Autism Other Dev Disabl. 2006;21(4):211–22. https://doi.org/
10.1177/10883576060210040201.
16. Gray C. The new social story book. Texas: Future Horizons; 2010.
17. National Research Council. Educating Children with Autism. Washington,
DC: The National Academies Press; 2001.
18. Ivey M, Heflin L, Alberto P. The use of Social Stories™ to promote
independent behaviors in novel events for children with PDD-NOS. Focus
Autism Other Dev Disabl. 2004;19(3):164–76. https://doi.org/10.1177/
10883576040190030401.
19. Crozier S, Tincani M. Effects of Social Stories™ on prosocial behaviour of
preschool children with Autism Spectrum Disorders. J Autism Dev Disord.
2007;37(9):1803–14. https://doi.org/10.1007/s10803-006-0315-7.
20. Delano M, Snell M. The effects of Social Stories™ on the social engagement
of children with autism. J Posit Behav Interv. 2006;8(1):29–42. https://doi.
org/10.1177/10983007060080010501.
21. Chan J, O'Reilly M. A Social Stories™ intervention package for students with
autism in inclusive classroom settings. J Appl Behav Anal. 2008;41(3):405–9.
https://doi.org/10.1901/jaba.2008.41-405.
22. Norris C, Dattilo J. Evaluating effects of a Social Story™ intervention on a
young girl with autism. Focus Autism Other Dev Disabl. 1999;14(3):180–6.
https://doi.org/10.1177/108835769901400307.
23. Barry L, Burlew S. Using Social Stories™ to teach choice and play skills to
children with autism. Focus Autism Other Dev Disabl. 2004;19(1):45–51.
https://doi.org/10.1177/10883576040190010601.
24. Ozdemir S. The effectiveness of Social Stories™ on decreasing disruptive
behaviors of children with autism: Three case studies. J Autism Dev Disord.
2008;38(9):1689–96. https://doi.org/10.1007/s10803-008-0551-0.
25. Bledsoe R, Myles B, Simpson R. Use of a Social Story™ intervention to
improve mealtime skills of an adolescent with Asperger syndrome. Autism.
2003;7(3):289–95. https://doi.org/10.1177/13623613030073005.
26. Lorimer P, Simpson R, Myles B, Ganz JB. The use of Social Stories™ as a
preventative behavioral intervention in a home setting with a child with
autism. J Posit Behav Interv. 2002;4(1):53–60. https://doi.org/10.1177/
109830070200400109.
27. Kuttler S, Myles BS, Carlson JK. The use of Social Stories™ to reduce
precursors to tantrum behaviours in a student with autism. Focus Autism
Other Dev Disabl. 1998;13:176–82. https://doi.org/10.1177/
108835769801300306.
28. Adams L, Gouvousis A, VanLue M, Waldron C. Social Story™ intervention:
improving communication skills in a child with an Autism Spectrum
Disorder. Focus Autism Other Dev Disabl. 2004;19(2):87–94. https://doi.org/
10.1177/10883576040190020301.
29. Quilty K. Teaching paraprofessionals how to write and implement Social
Stories™ for students with Autism Spectrum Disorders. Remedial Spec Educ.
2007;28(3):182–9. https://doi.org/10.1177/07419325070280030701.
30. Kokina A, Kern L. Social Story™ interventions for students with Autism
Spectrum Disorders: A meta-analysis. J Autism Dev Disord. 2010;40(7):812–
26. https://doi.org/10.1007/s10803-009-0931-0.
Wright et al. BMC Psychology            (2020) 8:60 Page 9 of 10
31. Reynhout G, Carter M. Social Stories™ for children with disabilities. J Autism
Dev Disord. 2006;36(4):445–69. https://doi.org/10.1007/s10803-006-0086-1.
32. Marshall D, Wright B, Allgar V, Adamson J, Williams C, Ainsworth A, et al.
Social Stories™ in mainstream schools for children with autism spectrum
disorder: a feasibility randomised controlled trial. BMJ Open. 2016;6(8):
e011748. https://doi.org/10.1136/bmjopen-2016-011748.
33. Williams C, Wright B. A guide to writing social stories™ step-by-step guidelines
for parents and professionals. London: Jessica Kingsley Publishers; 2017.
34. Constantino JN, Gruber CP. Social responsiveness scale–second edition (SRS-
2). Torrance: Western Psychological Services; 2012.
35. Abidin RR. Parenting stress index. Odessa: Psychological Assessment
Resources; 2012.
36. The EuroQol Group. EuroQol-a new facility for the measurement of health-
related quality of life. Health Policy. 1990;16(3):199–208. https://doi.org/10.
1016/0168-8510(90)90421-9.
37. Chorpita BF, Yim L, Moffitt C, Umemoto LA, Francis SE. Assessment of
symptoms of DSM-IV anxiety and depression in children: a Revised Child
Anxiety and Depression Scale. Behav Res Ther. 2000;38(8):835–55. https://
doi.org/10.1016/S0005-7967(99)00130-8.
38. Law D, Jacob J. Goals and goal based outcomes (GBOs): some useful
information. 3rd ed. London: CAMHS Press; 2015.
39. Pillay M, Alderson-Day B, Wright B, Willaims C, Urwin B. Autism Spectrum
Conditions--Enhancing Nurture and Development (ASCEND): An evaluation
of intervention support groups for parents. Clin Child Psychol Psychiatry.
2011;16(1):5–20. https://doi.org/10.1177/1359104509340945.
40. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated
guidelines for reporting parallel group randomised trials. BMC Med. 2010;
8(1):18. https://doi.org/10.1186/1741-7015-8-18.
41. Strauss A, Corbin J. Basics of qualitative research techniques. Thousand
Oaks: Sage Publications; 1998.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Wright et al. BMC Psychology            (2020) 8:60 Page 10 of 10
